NM_000102.4(CYP17A1):c.754-10_754-9insAA AND CYP17A1-related disorder

This record was updated by the submitter. Please see the current version.

Germline classification:: Likely benign (1 submission)
Last evaluated:: Aug 26, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003898637.1

Allele description

NM_000102.4(CYP17A1):c.754-10_754-9insAA

Genes:

CYP17A1-AS1:CYP17A1 antisense RNA 1 [Gene - HGNC]
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]

Variant type:

Insertion

Cytogenetic location:

10q24.32

Genomic location:

Preferred name:

NM_000102.4(CYP17A1):c.754-10_754-9insAA

HGVS:

NC_000010.11:g.102833217_102833218insTT
NG_007955.1:g.9316_9317insAA
NM_000102.3:c.754-10_754-9insAA
NM_000102.4:c.754-10_754-9insAAMANE SELECT
NC_000010.10:g.104592974_104592975insTT

Molecular consequence:

NM_000102.4:c.754-10_754-9insAA - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: CYP17A1-related disorder
Synonyms:: CYP17A1-related condition
Identifiers:

Recent activity

Clear Turn Off Turn On

RecName: Full=Heparin cofactor 2; AltName: Full=Heparin cofactor II; Short=HC-II...
RecName: Full=Heparin cofactor 2; AltName: Full=Heparin cofactor II; Short=HC-II; AltName: Full=Protease inhibitor leuserpin-2; AltName: Full=Serpin D1; Flags: Precursor
gi|2500775|sp|Q64268.1|HEP2_RAT

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004716379	PreventionGenetics, part of Exact Sciences	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely benign (Aug 26, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004716379

PreventionGenetics, part of Exact Sciences

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely benign
(Aug 26, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004716379.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine